The default mode network has dominated integration conversations for the better part of a decade. The DMN story is satisfying because it gives a network-level home to the felt sense of ego dissolution. But the DMN is not the only neural target that psilocybin pulls on, and it may not be the most upstream one. Across 900-plus integration sessions, the participants who develop the most durable insight tend to have a working mental model of mechanism, not only of phenomenology. A mechanistic model lets them locate what is changing and why, rather than treating the experience as a single black box labeled "mystical."
This article focuses on the claustrum, a thin subcortical sheet of gray matter that Crick and Koch in 2005 proposed as a candidate "conductor" of conscious experience (Crick and Koch, 2005). The claustrum is densely packed with 5-HT2A receptors, which is the same receptor classic psychedelics agonize. Barrett, Krimmel, Griffiths and colleagues in 2020, publishing in NeuroImage, gave us the first imaging data showing what psilocybin does to claustrum activity in a controlled human study (Barrett et al., 2020).
The frame for the rest of this piece is mechanistic and practical. The neuroscience matters because it changes what integration work is actually consolidating in the post-session window. For deeper coverage of adjacent systems, see the default mode network explained, glutamate and psychedelics, and the integration arc covered in the psychedelic afterglow window.
- The claustrum is a thin sheet of gray matter with reciprocal connections to nearly every cortical region, proposed by Crick and Koch in 2005 as a candidate "conductor" of conscious experience.
- The claustrum carries the densest 5-HT2A receptor expression in the cortex, the same receptor classic psychedelics agonize.
- Barrett and colleagues in 2020, in a 15-participant NeuroImage study, showed psilocybin reduced BOLD signal variance in the claustrum and altered its connectivity with the default mode network.
- Subjective drug-effect intensity correlated with the magnitude of claustrum BOLD signal change, suggesting a mechanistic, not incidental, role.
- Daws and colleagues in 2022, in Nature Medicine, linked network disintegration during the acute dose to antidepressant response weeks later, framing integration as a consolidation window.
What Is the Claustrum and Why Does It Matter?
The claustrum is a thin, irregular sheet of gray matter that lies beneath the neocortex on each side of the brain, with reciprocal connections to nearly every cortical region. Crick and Koch in 2005 proposed in Philosophical Transactions of the Royal Society B that this exceptional connectivity profile makes the claustrum a candidate "conductor" of conscious experience, binding diverse cortical signals into a unified perceptual field.
The conductor metaphor is precise. A symphony orchestra produces a unified sound because the conductor coordinates the timing of independent sections. Crick and Koch argued that the same coordination problem exists in the brain. Visual cortex, auditory cortex, prefrontal regions, somatosensory areas, all process in parallel. Something has to bind their outputs into a single experienced moment. The claustrum's reciprocal wiring to almost every cortical area made it the strongest anatomical candidate for that role.
The claustrum is hard to study. It is thin, irregular, and sits adjacent to white matter tracts that make standard fMRI segmentation difficult. Most early human imaging of the region was unreliable. Higher-resolution sequences and improved segmentation methods over the last decade have made it possible to read claustrum BOLD signal more cleanly, which is what enabled the Barrett 2020 study to land. In integration conversations, this is the structure I bring up when a participant describes the session as one where "everything became one thing" rather than one where specific content surfaced. The phenomenology maps onto a binding-failure story more cleanly than a content story.
Crick and Koch in 2005, publishing in Philosophical Transactions of the Royal Society B, proposed that the claustrum acts as a conductor of conscious experience by virtue of its reciprocal connections to nearly every cortical region. The argument is anatomical and inferential, not mechanistic in the experimental sense. The claustrum's wiring profile is unique in the cortex. Crick and Koch argued that any binding mechanism that solves the unity problem in conscious experience must have an anatomical substrate, and the claustrum is the strongest candidate that the connectivity data supports. The proposal has driven a decade of subsequent investigation into claustrum function across species.
The Barrett 2020 Study Showed Psilocybin Alters Claustrum Signal
Barrett, Krimmel, Griffiths and colleagues in 2020, publishing in NeuroImage with 15 healthy participants scanned after psilocybin and placebo, found that psilocybin reduced low-frequency BOLD signal variance in the claustrum and altered its functional connectivity with the default mode network. The magnitude of the subjective drug effects correlated with the magnitude of the claustrum BOLD signal change.
The design used a within-subject, double-blind, placebo-controlled crossover. Each participant was scanned after psilocybin and after placebo on separate sessions. Resting-state fMRI was acquired during the peak effect window. The researchers used a manually drawn, high-resolution claustrum mask to address the segmentation problem that has historically made claustrum imaging unreliable.
The Two Headline Findings
The first finding is that psilocybin reduced the variance of the low-frequency BOLD signal in the claustrum. Variance reduction in this context suggests the claustrum's normal fluctuating activity became flatter under psilocybin. The second finding is connectivity-based. Claustrum functional connectivity with the default mode network decreased, while connectivity with task-positive networks like the frontoparietal control network increased.
The Subjective Correlation
The most important finding for integration practitioners is the subjective correlation. The magnitude of the claustrum BOLD signal change tracked the intensity of the participants' subjective drug effects, measured by the 5-Dimensional Altered States of Consciousness scale. This is the data point that elevates the claustrum from "another region that lit up" to a candidate mechanistic node. Effects that correlate with phenomenology are more likely to be causally involved than effects that occur in parallel without correlation.
Why Is the 5-HT2A Density of the Claustrum Important?
The claustrum has been documented to carry the densest 5-HT2A receptor expression of any cortical region, which is the same receptor that classic psychedelics including psilocybin, LSD, DMT, and mescaline agonize. Receptor density alone does not prove mechanism, but the combination of density, anatomical connectivity, and the Barrett 2020 imaging data converges on a coherent story.
5-HT2A receptors are not evenly distributed across the cortex. They cluster in regions involved in higher-order integration, including prefrontal cortex, posterior cingulate, and the claustrum. The Barrett group and others have argued that psychedelic effects on conscious experience are best understood by mapping 5-HT2A density onto the regions whose activity changes most under the drug. The claustrum scores high on both dimensions, density and activity change.
The Receptor-Network Bridge
This is where the mechanistic story starts to cohere. Psilocybin binds 5-HT2A receptors. The claustrum has the highest 5-HT2A density. Psilocybin reduces claustrum BOLD signal variance and alters its connectivity with the DMN. The DMN is the network most associated with the sense of self. The chain of inferences runs from molecular target to network behavior to phenomenology. The integration implication is that the participant's experience of "self loosening" is not primarily a DMN event. It is plausibly a claustrum event whose downstream effects show up in the DMN, which is the network we have historically had better imaging tools to read.
The Glutamate Layer
The 5-HT2A story is also a glutamate story. 5-HT2A agonism on layer V pyramidal neurons drives glutamate release across the cortex. The claustrum's heavy 5-HT2A density makes it one of the regions where this glutamatergic surge is largest. For deeper coverage of how the glutamate cascade shapes the acute experience and the post-session plasticity window, see glutamate and psychedelics.
Barrett, Krimmel, Griffiths and colleagues in 2020, publishing in NeuroImage, scanned 15 healthy adults under psilocybin and placebo using resting-state fMRI with a high-resolution manually-drawn claustrum mask. The study reported reduced low-frequency BOLD signal variance in the claustrum under psilocybin, decreased claustrum-default mode network connectivity, and increased claustrum-task positive network connectivity. The magnitude of the BOLD signal change correlated with the intensity of subjective drug effects on the 5-Dimensional Altered States of Consciousness scale. The interpretation the authors offer is that psilocybin partially disengages the claustrum from its routine role of binding cortical activity into the default-mode self-model, which may contribute mechanistically to the ego dissolution phenomenology that defines the peak psychedelic experience.
How Does the Claustrum Connect to the Default Mode Network Story?
The default mode network is the named villain of the post-Carhart-Harris integration literature, but the Barrett 2020 finding reframes the DMN changes as downstream rather than primary. The claustrum may be the upstream node whose disengagement allows the DMN to lose its dominant grip on cortical activity, which is the change participants experience as ego dissolution.
The DMN is a set of regions active during self-referential thought, mind-wandering, and autobiographical recall. Under psilocybin, DMN connectivity decreases and the network's grip on cortical activity loosens. Carhart-Harris and colleagues built the entropic brain framework around this finding in the mid-2010s. The framework is still useful. But the claustrum data adds a layer the DMN story alone cannot explain. Why does the DMN loosen?
One Plausible Causal Chain
One causal chain is consistent with the available data. Psilocybin binds 5-HT2A receptors, concentrated in the claustrum. The claustrum's normal coordinating function is disrupted. Without the claustrum binding cortical activity into the routine DMN-dominated self-model, the DMN's grip loosens and other networks become more accessible. The phenomenology is the felt sense of the self becoming less rigid. The therapeutic relevance is that what then becomes available, new connections, new perspectives, new emotional content, can be integrated.
What Doss 2021 Adds
Doss and colleagues in 2021, publishing in Translational Psychiatry, showed that psilocybin acutely increased cognitive flexibility on standardized tasks, and that the DMN changes were associated with this cognitive flexibility shift (Doss et al., 2021). The integration relevance is that the window of increased flexibility is not just an in-session phenomenon. It extends into the days that follow, which is the window where new behaviors and perspectives can be tested and consolidated.
Why Should Integration Practice Care About the Claustrum?
Daws and colleagues in 2022, publishing in Nature Medicine, demonstrated that the magnitude of network disintegration during the acute psilocybin dose predicted antidepressant response weeks later (Daws et al., 2022). The clinical implication is that integration is not recovery from a temporary perturbation. It is consolidation of a structural shift that the dose initiated.
The Daws 2022 analysis pooled fMRI data from two psilocybin-for-depression trials. Greater functional disintegration of the brain's modular network structure during the acute dose correlated with greater symptom improvement at follow-up weeks later. The acute disintegration was not noise. It was the signal that predicted whether the antidepressant effect held.
The Plasticity Window Is the Lever
The four to six week window after a psilocybin session is where behavior, environment, and reflective practice shape which of the destabilized network configurations becomes the new resting baseline. In my practice, the participants who consolidate the network change are the ones who do specific things in this window. They reduce the autopilot loops they identified during the session. They sit with uncomfortable affect rather than displacing it. They make small structural changes in how they spend time. The ones who do not consolidate often return to the pre-session pattern within a month.
The Claustrum Reframe Sharpens the Conversation
When integration conversations are framed only around DMN and "ego," the practitioner often misses what the participant is reporting. A claustrum-binding-failure frame opens different questions. What perceptual fields stopped binding? What sensory or emotional channels became unusually vivid? What downstream pattern in waking life now shows that same unbinding quality? These are questions a pure DMN frame does not generate. They surface integration material the DMN story misses.
Daws and colleagues in 2022, publishing in Nature Medicine, analyzed fMRI data from two psilocybin-for-depression trials and showed that greater functional disintegration of the brain's modular network structure during the acute psilocybin dose predicted greater antidepressant response at follow-up weeks later. The finding is mechanistically important because it reframes integration. Acute network disintegration is not noise to recover from. It is the signal that predicts whether the antidepressant effect persists. The four to six week post-session plasticity window is the lever that determines which of the destabilized network configurations consolidates into the new resting baseline, which makes structured integration practice mechanistically load-bearing rather than optional supportive care.
The Current Claustrum Evidence Has Real Limits
The Barrett 2020 study enrolled 15 participants, which is a small sample even by neuroimaging standards, and the claustrum's anatomical thinness creates persistent segmentation challenges that complicate replication. The findings are biologically plausible and converge with the receptor density and connectivity data, but no single study should be treated as definitive. Replication in larger samples is ongoing.
Sample and Statistical Power
Small-sample fMRI studies have a well-documented replication problem across neuroscience broadly. Fifteen participants is on the lower end of contemporary psychedelic imaging samples, though the within-subject crossover design helps statistical power. The findings should be read as strong preliminary evidence, not as a closed case.
Segmentation Difficulty
The claustrum is thin and irregular, and reading its BOLD signal cleanly requires high-resolution sequences and manual or semi-automated segmentation. Different labs use different masks. Standardization is improving but is not complete. This is a methodological reason why claustrum findings can vary across studies more than findings from larger, more easily segmented structures.
What the Evidence Does Not Yet Show
The claustrum data does not yet establish causality. The claustrum changes correlate with subjective effects, but correlation in imaging data is not the same as a causal lesion or stimulation study. Animal work using chemogenetics or optogenetics to selectively manipulate claustrum activity is ongoing. For the integration practitioner, the honest stance is that the claustrum is a strong candidate mechanistic node whose role will likely be refined as the next wave of studies lands.
"The participants who land the most durable insight from a session tend to be the ones who carry a working model of mechanism alongside the phenomenology. The claustrum gives the mechanism a more honest shape than DMN-only framing does. It does not replace the DMN story. It supplies the upstream layer the DMN story has been missing."